Primary Needle Knife Fistulotomy Versus Conventional Cannulation Method

Not Applicable

Completed

• Conditions: Pancreatic Diseases; Sphincter of Oddi Dysfunction; Biliary Stricture; Common Bile Duct Stone; Malignant Hepatobiliary Neoplasm
• Interventions: Device: cannulation of ampulla of Vater

• Registration Number: NCT02916199
• Lead Sponsor: Gangnam Severance Hospital

Brief Summary

The aim of this study are to evaluate the feasibility of needle knife fistulotomy (NKF) as an initial procedure for biliary access in patients with biliary disease who are at increased risk for post-endoscopic retrograde endoscopic retrograde cholangiopancreatography (PEP) and to assess the incidence rate of complications including PEP between NKF and conventional cannulation methods.

Detailed Description

Endoscopic retrograde endoscopic retrograde cholangiopancreatography (ERCP) is widely used for the diagnosis and treatment of pancreatic and biliary tract disease. However, post-ERCP pancreatitis (PEP) is the most common adverse event following the procedure, ranging from 2% to 10% in nonselective cases, and it can cause substantial morbidity, mortality, or high medical costs. Recent advances in cannulation technique and accessories for biliary cannulation have contributed to reduce the incidence of PEP, but biliary cannulation can fail in 5% to 20% of cases of ERCP. Suprapapillary needle-knife fistulotomy (NKF), with or without large-diameter balloon dilation, has been used as a rescue method in cases of difficult biliary cannulation, and NKF was recommended as an initial approach to selective biliary cannulation in cases of repetitive unintentional pancreatic cannulation.9 Moreover, difficult biliary cannulation is known to be a risk factor for PEP, and it has been reported that NKF is associated with a low risk of PEP. Thus, we hypothesized that NKF may reduce the risk of PEP in patients who are at increased risk for PEP.

Study Timeline

• Study First Submitted: 2016-09-24
• Study First Submitted QC: 2016-09-25
• Study First Posted: 2016-09-27
• Study Start: 2016-10-04
• Primary Completion: 2017-11-28
• Study Completion: 2017-11-28
• Status Verified: 2019-01
• Last Update Submitted: 2019-01-29
• Last Update Posted: 2019-01-30

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 207

Inclusion Criteria

• Patient who submitted a written informed consent for the this trial, and 18 ~ 90 years old

• Patient who have naïve ampulla (no previous procedure was performed at ampulla)

• Patient who is suspected to have biliary obstruction or biliary disease

• Patient who is needed to have endoscopic retrograde cholangiopancreatography for treatment of biliary obstruction

• Patient who have risks of post-endoscopic retrograde cholangiopancreatography pancreatitis among bellows (at least one more);

  1. suspected biliary sphincter of Oddi dysfunction
  2. young age (18~50 years)
  3. female
  4. normal common bile duct diameter (≤9mm)
  5. normal serum bilirubin level
  6. Obesity (body mass index > 30)
  7. Past history of acute pancreatitis

Exclusion Criteria

• Patient who is below 18 year old

• Patient who is pregnant

• Patient with mental retardation

• Patient is sensitive to contrast agents

• Patient who received sphincterotomy or pancreatobiliary operation previously

• Patient who have ampulla of Vater cancer

• Patient who have difficulty for approach to ampulla due to abdominal surgery including stomach cancer with Billroth II anastomosis

• Patient who have pancreatic diseases as bellow (at least one more);

  1. Patient who have acute pancreatitis within 30days before enrollment
  2. Patient who have idiopathic acute recurrent pancreatitis
  3. Patient who have pancreatic divisum
  4. Patient who have obstructive chronic pancreatitis
  5. Patient who pancreatic cancer

• Patients who have improper ampulla shape as bellows;

  1. Small ampulla (ampulla without oral protrusion)
  2. Flat or crooked or asymmetric ampulla
  3. Ampulla with peri-ampullary diverticulum type I or II

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Needle knife fistulotomy	cannulation of ampulla of Vater	Device: Needle knife fistulotomy Disease: Common bile duct stone, Malignant biliary stricture, Benign biliary stricture, Benign pancreatic disease, biliary sphincter of Oddi dysfunction Indication: High risk of post-endoscopic retrograde cholangiopancreatography pancreatitis - Intervention: canulation of ampulla of Vater Intervention: canulation of ampulla of Vater
conventional cannulation	cannulation of ampulla of Vater	Device: conventional canulation catheter Disease: Common bile duct stone, Malignant biliary stricture, Benign biliary stricture, Benign pancreatic disease, biliary sphincter of Oddi dysfunction Indication: High risk of post-endoscopic retrograde cholangiopancreatography pancreatitis - Intervention: canulation of ampulla of Vater Intervention: canulation of ampulla of Vater

Primary Outcome Measures

Name	Time	Method
Incidence rate of post-endoscopic retrograde cholangiopancreatography	1 week

Secondary Outcome Measures

Name	Time	Method
Incidence rate of complications including bleeding, perforation and infection	1 week
Success rate of stone removal	1 day
Success rate of cannulation	1 day

Trial Locations

Locations (7)

CHA Bundang Medical Center; 🇰🇷 Seongnam, Bundang-gu, Korea, Republic of

Gangnam Severance Hospital; 🇰🇷 Seoul, Gangnam-gu, Korea, Republic of

Dongtan Sacred Heart Hospital; 🇰🇷 Hwaseong-si, Gyeonggi-do, Korea, Republic of

In Ha University Hospital; 🇰🇷 Incheon, Jung-gu, Korea, Republic of

Soon Chun Hyang University Hospital, Cheonan; 🇰🇷 Cheonan, Namdong-gu, Korea, Republic of

Gachon University Gil Medical Center; 🇰🇷 Incheon, Namdong-gu, Korea, Republic of

Pusan National University Hospital; 🇰🇷 Busan-si, Seo-gu, Korea, Republic of